These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial". Kedhi E; Fabris E; van der Ent M; Kennedy MW; Buszman P; von Birgelen C; Cook S; Wedel H; Zijlstra F Am Heart J; 2017 Jun; 188():11-17. PubMed ID: 28577666 [TBL] [Abstract][Full Text] [Related]
6. Current developments in dual antiplatelet therapy after stenting. Giacoppo D; Baber U; Mehran R Minerva Cardioangiol; 2014 Jun; 62(3):261-76. PubMed ID: 24831762 [TBL] [Abstract][Full Text] [Related]
7. Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? Christodoulidis G; Baber U; Mehran R Curr Opin Cardiol; 2014 Jul; 29(4):301-6. PubMed ID: 24842783 [TBL] [Abstract][Full Text] [Related]
8. [ANMCO/ANCE/ARCA/GICR-IACPR intersociety consensus document: long-term antiplatelet therapy in patients with coronary artery disease]. Gulizia MM; Colivicchi F; Abrignani MG; Ambrosetti M; Aspromonte N; Barile G; Caporale R; Casolo G; Chiuini E; Di Lenarda A; Faggiano P; Gabrielli D; Geraci G; La Manna AG; Maggioni AP; Marchese A; Massari FM; Mureddu GF; Musumeci G; Nardi F; Panno AV; Pedretti RFE; Piredda M; Pusineri E; Riccio C; Rossini R; Scotto Di Uccio F; Urbinati S; Varbella F; Zito GB; De Luca L G Ital Cardiol (Rome); 2018 May; 19(5):263-331. PubMed ID: 29853716 [TBL] [Abstract][Full Text] [Related]
9. Bleeding versus thrombosis: role of short DAPT in complex lesions. Calcagno S; Lucisano L; Mancone M; Cavallo E; Pennacchi M; Stio RE; Sardella G Minerva Cardioangiol; 2015 Dec; 63(6):533-46. PubMed ID: 26334115 [TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting. Knijnik L; Fernandes M; Rivera M; Cardoso R; Goyal A; Liberman H; Sperling LS; McDaniel MC Am J Cardiol; 2021 Jul; 151():25-29. PubMed ID: 34049672 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. Povsic TJ; Roe MT; Ohman EM; Steg PG; James S; Plotnikov A; Mundl H; Welsh R; Bode C; Gibson CM Am Heart J; 2016 Apr; 174():120-8. PubMed ID: 26995378 [TBL] [Abstract][Full Text] [Related]
12. Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence. Montalescot G; Brieger D; Dalby AJ; Park SJ; Mehran R J Am Coll Cardiol; 2015 Aug; 66(7):832-847. PubMed ID: 26271067 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study. Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518 [TBL] [Abstract][Full Text] [Related]
19. Dual antiplatelet therapy after drug-eluting stents: defining the proper duration. Park SJ; Kang SM; Park DW Coron Artery Dis; 2014 Jan; 25(1):83-9. PubMed ID: 24322887 [TBL] [Abstract][Full Text] [Related]